Skip to Content

We provide the following professional services, staff augmentation and consulting support to the pharmaceutical and medical devices industry:

  • Contract Qualified Person according to Article 48 of Directive 2001/83/EC.
  • Contract Responsible Person according to EU GDP guide (2013/C 343/01).
  • Contract RP & RPi according to the UK Human Medicines Regulation 2012.
  • Quality, regulatory and pharmacovigilance support
  • Due diligence and gap analysis for mergers, acquisitions, and carve-outs.
  • Vendor Management, including GMP, GDP and GVP Audits.
  • Quality Management System (QMS) development, implementation & embedding.
  • Training on key disciplines such as GMDP, Root Cause Analysis, Batch Review, Auditing, Data Integrity and Quality Risk Management.
  • Pharmaceutical MIA/ MIA (IMP) and WDA licence application and support.
  • QA/PV/Reg support including Bonafides, Deviations, complaints, safety reviews, local PV contact.

Orion GXP Consulting - Our Services

QP Services

Most of our consultants are QPs and we have a wide pool available specialising in all dosage forms and technologies.  Our QPS are ready to be listed on client MIA/MIA-IMPs and carry out batch release according to Directive 2001/83/EC (Human), Regulation (EU) No 536/2014 (clinical) and Regulation (EU) 2019/6 (veterinary).

Find Out More

RP and RPi Services

For GDP and distribution, we provide interim Responsible Persons and Responsible Persons for import services to the pharmaceutical industry. We have RPs available across the UK and Ireland and RPIs in the UK, and we also provide these GDP experts for short-term or long-term consulting projects.

Find Out More

QMS Development
& Licencing

We assist clients in expanding their range of products and launching products in new territories by developing the required licensing and QMS requirements. This includes writing new procedures, identifying additional resources, assisting with the necessary licence applications, and completing any remediation work needed.

Find Out More

Vendor Management and Audit services

We have built a strong team of GxP audit professionals with decades of experience in GMDP audits of global pharmaceutical drug substances, drug product suppliers, and wholesalers, including third-party logistics partners. We can also assist with mock facility inspections and vendor qualification using a mix of on-site, survey, and remote inspection capabilities.

Find Out More

Training and site support

We work with our clients to ensure that the correct quality culture is embedded in their organisation by training the staff in the core principles of GMP, GDP, or GCP. We offer detailed step-by-step courses in a wide variety of quality, manufacturing, regulatory and engineering disciplines.

Find Out More

Regulatory, Pharmacovigilance and CMC Support

We assist our clients by providing regulatory, pharmacovigilance, and CMC subject matter experts with decades of experience in dossier preparation, compliance reviews, MA applications, and dealing with EMA and National Competent AuthoritiesWe can also assist with Marketing Authorisation sourcing and MA Transfers and holding.

Find Out More

Latest News

Our team of experienced consultants are ready to help, and they have global experience across the healthcare industry.

Charley
Nov 18,2024
The regulation of combination products, those that integrate medicinal products with medical devices, is a complex area within medical products regulation. Due to their hybrid nature, combination products challenge conventional regulatory pathways, demanding a nuanced approach to ensure their safety, efficacy, and quality.
Charley
Nov 04,2024
MDR has also presented considerable challenges for manufacturers, importers, and distributors as they attempt to meet its complex regulatory requirements. This week, I wanted to discuss the challenges and increased scrutiny that MDR compliance imposes on these entities and explore how regulatory bodies are enforcing these standards.
Charley
Oct 17,2024
It is crucial to validate the transport of medicinal products under representative conditions in order to ensure their quality, safety, and efficacy throughout the supply chain. The Good Distribution Practice (GDP) guidelines for medicinal products, which were introduced in 2013, place significant emphasis on safeguarding products during transportation to prevent risks such as temperature excursions, contamination, or damage. By following these guidelines for transport validation, stakeholders
Charley
Sep 18,2024
This week, I want to delve into the processes involved in conducting clinical trials in the EU with a brief introduction to what clinical trials are and then to give an overview of the main guidelines and legislation. I will focus on regulatory frameworks, ethical considerations, and the steps taken to ensure public safety and trust.

Meet Our Directors

Our leadership team is made up of experienced consultants who are ready to help, and they have global experience across the healthcare industry.

 

Charley Maxwell

MANAGING DIRECTOR

Nirmal Kaur Tarry

ASSOCIATE DIRECTOR RP/RPi - UK

Patricia Grimes

Associate Director QP/RP - Ireland

Contact Details

IRL Address:

W8 Centre,
Curch Lane, Manorhamilton,
County Leitrim,
F91 H2YA
Ireland

UK Address:

6b Upper Water Street,
Newry,
Co Down,
BT34 1DJ
Northern Ireland


Ireland Number

+353 71 98 10101


UK Number

+44 203 475 0375

Need our help?

Request and appointment or submit a scope today and one of our specialists will review it and get back to you straight away.

* Denotes required field
Send Contact Form